title: Polymyositis during pegylated alpha-interferon ribavirin therapy for chronic hepatitis.
authors: Anil
authors: A
authors: John
authors: Samar
authors: S
authors: El Emadi
authors: Saad
authors: S
authors: Al Kaabi
authors: Nader
authors: N
authors: Morad
authors: Moutaz
authors: M
authors: Derbala
authors: Rafie
authors: R
authors: Yakoub
authors: Nazeeh
authors: N
authors: Dweik
authors: Mohammed Tariq
authors: MT
authors: Butt
mesh_terms: D005260:Female; D019698:Hepatitis C, Chronic / Q000150:complications / Q000178:diet therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects*; D008875:Middle Aged; D011092:Polyethylene Glycols / Q000008:administration & dosage / Q000009:adverse effects*; D017285:Polymyositis / Q000139:chemically induced*; D011994:Recombinant Proteins; D012254:Ribavirin / Q000008:administration & dosage*
chemical_list: D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C100416:peginterferon alfa-2a